Hot Investor Mandate 1: Europe-Based VC Invests in Groundbreaking Therapeutic, Medical Devices, Diagnostic and Digital Health Startups

21 Sep

A life sciences and healthcare venture capital firm founded in 2014 is looking for global investment opportunities. The firm’s LPs include a pharma company and a government-owned fund of funds. The firm is currently allocating out of its $35M fund and actively seeking investment opportunities. The firm will typically participate in Seed to Series B rounds with initial sizes of investment ranging from $0.5M to $2.5M, and will earmark $1-3M for follow-on investments. The firm invests globally.

The firm is looking for companies with groundbreaking science and technology, and invests broadly across therapeutics, medical devices, diagnostics, and healthcare IT. The firm’s strongest expertise lies in therapeutics and they have invested the most in this sector. The firm will consider any asset from pre-clinical to phase II. The firm is open to all indications but is more selective when reviewing companies in overcrowded indications such as oncology.

The firm seeks innovative, high growth potential companies led by strong management teams, particularly with strong scientific expertise. The firm prefers to lead or co-lead investment rounds, especially if they are participating in Seed to Series A. They are also open to co-investing alongside other investors.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: